The pharmaceutical industry relies on a vast array of chemical compounds as building blocks for innovative medicines and diagnostic tools. Among these, Nicotinamide Adenine Dinucleotide (NAD+), a vital coenzyme, stands out for its significant potential as a pharmaceutical intermediate. Its involvement in fundamental metabolic pathways makes it invaluable for both in vitro diagnostics (IVD) and the complex process of new drug development.

In the realm of in vitro diagnostics, NAD+ serves as a crucial reagent in various biochemical assays. Many diagnostic tests, particularly those measuring enzyme activity or metabolic markers, utilize NAD+ as a substrate or cofactor. The accurate quantification of NAD+ itself can also be important for diagnosing certain metabolic disorders. Therefore, the availability of highly pure NAD+ is essential for the reliability and precision of these diagnostic kits.

Beyond diagnostics, NAD+ plays a pivotal role in new drug development. Researchers are continually investigating NAD+'s therapeutic potential, exploring its impact on a range of conditions from metabolic diseases to neurodegenerative disorders. As a key molecule in cellular energy and repair, NAD+ and its precursors are targets for novel therapeutic strategies. The synthesis of complex drug molecules often requires high-quality intermediates like NAD+ to ensure the efficacy and safety of the final pharmaceutical product.

NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical need for high-purity pharmaceutical intermediates. We are dedicated to supplying premium NAD+ powder that meets the stringent requirements of the pharmaceutical sector. Our commitment ensures that researchers and manufacturers have access to a reliable and high-quality source of NAD+ for their groundbreaking work.

By providing top-tier NAD+ powder, NINGBO INNO PHARMCHEM CO.,LTD. actively supports the advancement of medical science. We are proud to be a key partner in the development of new diagnostics and therapies that can improve global health outcomes.